Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension
- Conditions
- Hypertension
- First Posted Date
- 2005-08-29
- Last Posted Date
- 2011-11-08
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 259
- Registration Number
- NCT00136851
- Locations
- 🇺🇸
Novartis Pharmaceuticals, East Hanover, New Jersey, United States
Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary Disease
- Conditions
- Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2005-08-25
- Last Posted Date
- 2011-10-25
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 847
- Registration Number
- NCT00134979
Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)
- Conditions
- Gastrointestinal Stromal Tumors
- Interventions
- Drug: AMN107, STI571
- First Posted Date
- 2005-08-25
- Last Posted Date
- 2020-12-08
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 59
- Registration Number
- NCT00135005
- Locations
- 🇮🇹
Novartis Investigative Site, Milano, MI, Italy
Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and Older
- First Posted Date
- 2005-08-22
- Last Posted Date
- 2016-09-12
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 581
- Registration Number
- NCT00132808
- Locations
- 🇺🇸
For information regarding facilities, please contact the Central Contact, E. Hanover, New Jersey, United States
Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta
- Conditions
- Osteogenesis Imperfecta
- First Posted Date
- 2005-08-17
- Last Posted Date
- 2017-06-01
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 127
- Registration Number
- NCT00131118
- Locations
- 🇺🇸
UCLA Medical Center-Dept of Pediatric Nephrology, Los Angeles, California, United States
🇺🇸Intermountains Orthopedics, Boise, Idaho, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification
- First Posted Date
- 2005-07-28
- Last Posted Date
- 2011-03-23
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 1091
- Registration Number
- NCT00124709
- Locations
- 🇺🇸
Children's Medical Group, Hopewell Junction, New York, United States
🇺🇸Central Dermatology, St Louis, Missouri, United States
🇺🇸Rx R & D, Metarie, Louisiana, United States
Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)
- First Posted Date
- 2005-07-28
- Last Posted Date
- 2012-02-03
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 476
- Registration Number
- NCT00124748
- Locations
- 🇺🇸
Palm Beach Cancer Institute, West Palm Beach, Florida, United States
🇺🇸LSU Health Scine Center, Shreveport, Louisiana, United States
🇺🇸St. Agnes Hospital, Baltimore, Maryland, United States
Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
- First Posted Date
- 2005-07-27
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 85
- Registration Number
- NCT00124280
- Locations
- 🇺🇸
Nevada Cancer Institute, Las Vegas, Nevada, United States
🇺🇸MD Anderson Cancer Center, Department of Thoracic /Head and Neck Medical Oncology, Houston, Texas, United States
Study of Oral AEE788 in Adults With Advanced Cancer
- First Posted Date
- 2005-07-11
- Last Posted Date
- 2012-01-09
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 189
- Registration Number
- NCT00118456
- Locations
- 🇺🇸
Yale Cancer Center, New Haven, Connecticut, United States
🇺🇸Sarah Cannon Research Institute, Nashville, Tennessee, United States
🇺🇸Nevada Cancer Institute, Las Vegas, Nevada, United States
Terbinafine Compared to Griseofulvin in Children With Tinea Capitis
- Conditions
- Tinea Capitis
- Interventions
- First Posted Date
- 2005-07-08
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 720
- Registration Number
- NCT00117767
- Locations
- 🇺🇸
Novartis Pharmaceuticals, East Hanover, New Jersey, United States